XBI
State Street SPDR S&P Biotech ETF (XBI) ETF Research
Research State Street SPDR S&P Biotech ETF (XBI) with fund profile, issuer, category, tracked index, holdings context and related market news.
- Ticker
- XBI
- Fund
- State Street SPDR S&P Biotech ETF
- Issuer
- State Street
- Category
- Sector ETF
- Exchange
- NYSEARCA
- Assets under management
- $7.87B
- Expense ratio
- 0.35%
- Dividend yield
- 0.36%
- Tracked index
- S&P Biotechnology Select Industry Index
- Largest holding
- Apogee Therapeutics, Inc.
- Top holding weight
- 1.51%
- Year-to-date return
- 0%
- Risk level
- High
- Inception date
- 2006-01-31
State Street SPDR S&P Biotech ETF (XBI) ETF Research research
This server-rendered page presents the available Be The Investor fund research for State Street SPDR S&P Biotech ETF. It gives search engines and readers direct access to the core profile for XBI, including its issuer, category, tracked index and holdings context when those data are available.
Use the full interactive page to compare the fund with alternatives and review concentration, costs, performance and portfolio fit. Fund data changes over time and should be confirmed with the issuer before investing.